Okuda Hiroshi, Takahashi Satoshi, Takaori-Kondo Akifumi, Yokoyama Akihiko
a Laboratory for Malignancy Control Research , Kyoto University Graduate School of Medicine , Kyoto , Japan.
b Department of Hematology and Oncology , Graduate School of Medicine , Kyoto , Japan.
Cell Cycle. 2016 Oct 17;15(20):2712-22. doi: 10.1080/15384101.2016.1222337. Epub 2016 Aug 26.
Gene rearrangement of the mixed lineage leukemia (MLL) gene causes leukemia by inducing the constitutive expression of a gene subset normally expressed only in the immature haematopoietic progenitor cells. MLL gene rearrangements often generate fusion products of MLL and a component of the AF4 family/ENL family/P-TEFb (AEP) complex. MLL-AEP fusion proteins have the potential of constitutively recruiting the P-TEFb elongation complex. Thus, it is hypothesized that relieving the promoter proximal pausing of RNA polymerase II is the rate-limiting step of MLL fusion-dependent transcription. AEP also has the potential to recruit the mediator complex via MED26. We recently showed that AEP activates transcription initiation by facilitating TBP loading to the TATA element through the SL1 complex. In the present study, we show that the key activity responsible for the oncogenic property of MLL-AEP fusion proteins is the TBP loading activity, and not the mediator recruitment or transcriptional elongation activities. Thus, we propose that TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.
混合谱系白血病(MLL)基因的重排通过诱导通常仅在未成熟造血祖细胞中表达的一个基因子集的组成性表达来引发白血病。MLL基因重排常常产生MLL与AF4家族/ENL家族/P-TEFb(AEP)复合物的一个组分的融合产物。MLL-AEP融合蛋白具有组成性募集P-TEFb延伸复合物的潜力。因此,有人提出,缓解RNA聚合酶II在启动子近端的暂停是MLL融合依赖性转录的限速步骤。AEP也具有通过MED26募集中介复合物的潜力。我们最近表明,AEP通过促进TBP经SL1复合物加载到TATA元件来激活转录起始。在本研究中,我们表明,负责MLL-AEP融合蛋白致癌特性的关键活性是TBP加载活性,而非中介募集或转录延伸活性。因此,我们提出,AF4经SL1进行的TBP加载是MLL融合依赖性转录中的主要限速步骤。